论文部分内容阅读
我国医药市场处于快速增长期。新医疗改革背景下,政府增加卫生投入,医疗保险覆盖面扩大,以及经济增长、人口老龄化等众多因素拉动医药经济快速增长。医药流通企业作为医药市场扩容最直接的受益者,将有非常大的成长空间。本文选取上海医药集团这一典型企业为研究对象,从财务管理的角度出发,运用杜邦分析的理论,系统全面地分析其财务状况,为其进一步成长寻求科学对策,以此探索整个医药流通业未来的发展趋势。
China’s pharmaceutical market is in a period of rapid growth. Under the background of new medical reform, the government has boosted the rapid growth of the pharmaceutical economy due to many factors including increasing investment in health care, expanding medical insurance coverage, and economic growth and population aging. Pharmaceutical distribution enterprises as the most direct beneficiaries of expansion of the pharmaceutical market, there will be very large room for growth. This paper chooses the typical enterprise of Shanghai Pharmaceutical Group as the research object, uses the theory of DuPont Analysis from the perspective of financial management, systematically and comprehensively analyzes its financial status and seeks for a scientific solution for its further growth, so as to explore the future of the entire pharmaceutical distribution industry The trend of development.